Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
Learn More
Human LILRB5/CD85c/LIR-8 Antibody, R&D Systems™

Goat Polyclonal Antibody has been used in 4 publications
Supplier: R&D Systems AF3065
This item is not returnable.
View return policy
Description
LIR-8/CD85c/LILRB5 Polyclonal specifically detects LIR-8/CD85c/LILRB5 in Human samples. It is validated for Western Blot, Flow Cytometry, CyTOF-ready.Specifications
LIR-8/CD85c/LILRB5 | |
Polyclonal | |
Unconjugated | |
O75023 | |
LILRB5 | |
Mouse myeloma cell line NS0-derived recombinant human LILRB5/CD85c/LIR-8 Arg18-His456 Accession # O75023 | |
100 μg | |
Primary | |
Detects human LILRB5/CD85c/LIR-8 in direct ELISAs and Western blots. In direct ELISAs, approximately 20% cross-reactivity with recombinant human (rh) LIR-4/ILT6 is observed, and approximately 10% cross-reactivity with rhILT5, rhLIR-5/ILT3, rhLIR-6, and rhLILRA5 is observed, and less than 5% cross-reactivity with rhILT2, rhILT4, and rhLIR-7 is observed. | |
Human | |
IgG |
Western Blot, Flow Cytometry, CyTOF | |
LYOPH | |
Western Blot 0.1 ug/mL, Flow Cytometry 2.5 ug/10^6 cells, CyTOF-ready | |
CD85 antigen-like family member C, CD85c, CD85c antigen, Leukocyte immunoglobulin-like receptor 8, leukocyte immunoglobulin-like receptor, subfamily B (with TM and ITIM domains), LIR8, LIR-8, LIR8CD85C, LIR-8leukocyte immunoglobulin-like receptor subfamily B member 5, member 5 | |
Goat | |
Affinity Purified | |
RUO | |
10990 | |
Reconstitute at 0.2 mg/mL in sterile PBS. | |
Use a manual defrost freezer and avoid repeated freeze-thaw cycles. 12 months from date of receipt, -20 to -70 degreesC as supplied. 1 month, 2 to 8 degreesC under sterile conditions after reconstitution. 6 months, -20 to -70 degreesC under sterile conditions after reconstitution. |
Product Content Correction
Your input is important to us. Please complete this form to provide feedback related to the content on this product.
Product Title
Spot an opportunity for improvement?Share a Content Correction